Search results
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
Zacks via Yahoo Finance· 7 hours agoThe FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for...
EC grants orphan status to Rocket Pharma's heart therapy By Investing.com
Investing.com· 4 hours agoThis designation is for the treatment of plakophilin-2 related arrhythmogenic cardiomyopathy...
AB Science provides an update on the application for conditional marketing authorisation of...
Benzinga· 6 hours agoFR0010557264 - AB) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ...
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 12 hours agoJune 2020, brensocatib received Breakthrough Therapy Designation from the FDA and was later granted...
Opinion | Want the best sunscreens this summer? The FDA is blocking you.
MSNBC via Yahoo News· 2 days agoAmericans visiting beaches in France, Spain or Italy can do something that’s illegal back home:...
St. Louis firm, backed by $200M in funding, gets regulatory nods to ‘expedite’ review of cancer drug...
The Business Journals· 2 days agoFood and Drug Administration’s Regenerative Medicine Advanced Therapy (RMAT) and European Medicines ...
EC approves Celltrion’s Omlyclo for allergic conditions
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe approval is granted to treat chronic spontaneous urticaria (CSU), allergic asthma and chronic...
‘I couldn’t orgasm’: Why anti-depressants could ruin your sex life
The Telegraph via Yahoo News· 4 days agoA few years ago, I found myself struggling with low mood and anxiety. It had come on gradually,...
Public-private collaboration aims to take ALS therapies beyond ‘a shot in the dark’
FierceBiotech· 5 hours agoIn 2015, after spending nearly four decades grinding his way up the ladder at one of the world’s...
EMA accepts HLX14 application from Henlius and Organon By Investing.com
Investing.com· 5 days agoDenosumab is utilized for conditions including osteoporosis in postmenopausal women at high risk for fracture. The applications for HLX14, which is under investigation as a biosimilar to the ...